DBV Technologies

DBV

FR0010417345

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:09 2024-04-19 am EDT			After market 12:13:20 pm
1.24 ^EUR	-0.96%		1.238	-0.16%

05:11pm	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	MT
Apr. 17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT

Dbv Technologies S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 02, 2021 at 11:30 pm EDT

DBV Technologies S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was USD 2.941 million compared to USD 4.720 million a year ago. Net loss was USD 29.449 million compared to USD 40.913 million a year ago.

Latest news about DBV Technologies

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	11:11am	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	Apr. 11	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 10	MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	Apr. 08	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	Apr. 01	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	Mar. 28	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	Mar. 25	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading	Mar. 22	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	Mar. 12	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	Mar. 11	MT
DBV Technologies: down sharply, cash flow not reassuring	Mar. 08	CF
DBV Technologies S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Transcript : DBV Technologies S.A., 2023 Earnings Call, Mar 07, 2024	Mar. 07
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Feb. 28	MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	Feb. 27	MT
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...	Feb. 21
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Tuesday Trading	Feb. 20	MT
DBV Technologies: share price falls as Xolair receives green light in the USA	Feb. 19	CF
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Feb. 15	MT

Chart DBV Technologies

Duration

Period

More charts

Company Profile

DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.

Sector

Pharmaceuticals

Calendar

2024-05-01 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for DBV Technologies

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.252 EUR

Average target price

4.783 EUR

Spread / Average Target

+282.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
DBV TECHNOLOGIES	-32.94%	128M
KYOWA KIRIN CO. LTD.	+10.08%	9.12B
SK BIOPHARMACEUTICALS CO., LTD.	-15.94%	4.8B
YUHAN CORPORATION	+1.89%	3.8B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+18.47%	3.72B
INDIVIOR PLC	+27.76%	2.58B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-26.11%	2.36B
BETTA PHARMACEUTICALS CO., LTD.	-29.37%	2.11B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+7.15%	1.86B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals